JT
DNTH icon

Jupiter Topco’s Dianthus Therapeutics DNTH Stock Holding History

Jupiter Topco’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
+15,500
New +$1.35M ﹤0.01% 1603

Other funds holding DNTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Jupiter Topco's DNTH Position: Q2 2026 in Review

Jupiter Topco opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 15,500 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #1603 among its holdings.

244 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Jupiter Topco held 15,500 shares of Dianthus Therapeutics worth $1.51M as of Q2 2026.
  • Dianthus Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Dianthus Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1603 holding.
  • 244 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.